Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial)
Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial)
About this item
Full title
Author / Creator
Mentz, Robert J., MD , Hasselblad, Vic, PhD , DeVore, Adam D., MD , Metra, Marco, MD , Voors, Adriaan A., MD , Armstrong, Paul W., MD , Ezekowitz, Justin A., MBBCh , Tang, W.H. Wilson, MD , Schulte, Phillip J., PhD , Anstrom, Kevin J., PhD , Hernandez, Adrian F., MD, MHS , Velazquez, Eric J., MD and O'Connor, Christopher M., MD
Publisher
United States: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
Furosemide is the most commonly used loop diuretic in patients with heart failure (HF) despite data suggesting potential pharmacologic and antifibrotic benefits with torsemide. We investigated patients with HF in Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure who were discharged on either torsemide or furosemide....
Alternative Titles
Full title
Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial)
Authors, Artists and Contributors
Author / Creator
Hasselblad, Vic, PhD
DeVore, Adam D., MD
Metra, Marco, MD
Voors, Adriaan A., MD
Armstrong, Paul W., MD
Ezekowitz, Justin A., MBBCh
Tang, W.H. Wilson, MD
Schulte, Phillip J., PhD
Anstrom, Kevin J., PhD
Hernandez, Adrian F., MD, MHS
Velazquez, Eric J., MD
O'Connor, Christopher M., MD
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4718787
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4718787
Other Identifiers
ISSN
0002-9149
E-ISSN
1879-1913
DOI
10.1016/j.amjcard.2015.10.059
